High-risk papillomavirus infection is associated with altered antibody responses in genital tract: Non-specific responses in HPV infection

Viral Immunology

Volumn 17, Issue 3, 2004, Pages 381-389

  Bard, E ^a   Riethmuller, D ^b   Meillet, D ^a   Pretet J L ^a   Schaal, J P ^b   Mougin, C ^a   Seillès, Estelle ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b HÔPITAL SAINT JACQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOFERRIN; LYSOZYME; SECRETORY IMMUNOGLOBULIN; VIRUS ANTIBODY;

ADULT; ARTICLE; CONDYLOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL TRACT INFECTION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMA VIRUS; VAGINA SECRETION; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CERVIX UTERI; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; LACTOFERRIN; MIDDLE AGED; MURAMIDASE; PAPILLOMAVIRUS INFECTIONS; SERUM ALBUMIN; VAGINA;

DNA VIRUSES; PAPILLOMAVIRUS;

EID: 4544260057     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2004.17.381     Document Type: Article

References (41)

1. Ashley, R.L., L. Corey, J. Dalessio, et al. 1994. Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections. J. Infect. Dis. 170:20-26.
2. Bard, E., S. Laibe, S. Clair, et al. 2002. Nonspecific secretory immunity in HIV-infected patients with oral candidiasis. J. Acquir. Immune Defic. Syndr. 31:276-284.
3. Bard, E., D. Riethmuller, S. Biichle, et al. 2002. Validation of high sensitive immuno-enzymatic assay to establish the origin of immunoglobulins in female genital secretions. J. Immunoassay 23:145-162.
4. Belec, L., T. Dupre, T. Prazuck, et al. 1995. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J. Infect. Dis. 172:691-697.
5. Belec, L., G. Gresenguet, M.A. Dragon, et al. 1994. Detection of antibodies to human immunodeficiency virus in vaginal secretions by immunoglobulin G antibody capture enzyme-linked immunosorbent assay: application to detection of seminal antibodies after sexual intercourse. J. Clin. Microbiol. 32:1249-1255.
6. Belec, L., A. Jean Georges, M.C. Hallouin, et al. 1996. Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions. AIDS Res. Hum. Retroviruses 12:157-167.
7. Bontkes, H.J., T.D. de Gruijl, J.M. Walboomers, et al. 1999. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. J. Gen. Virol. 80:409-417.
8. Bosch, F.X., M.M. Manos, N. Munoz, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87:796-802.
9. Brandtzaeg, P., A.E. Berstad, I.N. Farstad, et al. 1997. Mucosal immunity - a major adaptive defence mechanism. Behring Inst. Mitt. 1-23.
10. Combita, A.L., M.M. Bravo, A. Touze, et al. 2002. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in Colombian women with invasive cervical cancer. Int. J. Cancer 97:796-803.
11. Coutlee, F., C. Hankins, and N. Lapointe. 1997. Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. J. Med. Virol. 51:42-47.
12. Crowley-Nowick, P.A., M. Bell, R.P. Edwards, et al. 1995. Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion. Am. J. Reprod. Immunol. 34:241-247.
13. Delacroix, D.L. 1985. The Human Immunoglobulin: A system, Its Vascular Compartment, Vol. 1. Catholic University, Louvain, Belgium.
14. Delacroix, D.L., and J.P. Vaerman. 1982. Influence of molecular size of IgA on its immunoassay by various techniques. III. Immunonephelometry. J. Immunol. Methods 51:49-55.
15. Dillner, J. 1999. The serological response to papillomaviruses. Semin. Cancer Biol. 9:423-430.
16. Edwards, J.N., and H.B. Morris. 1985. Langerhans' cells and lymphocyte subsets in the female genital tract. Br. J. Obstet. Gynaecol. 92:974-982.
17. Frazer, I.H., R. Thomas, J. Zhou, et al. 1999. Potential strategies utilised by papillomavirus to evade host immunity. Immunol. Rev. 168:131-142.
18. Giannini, S.L., W. Al-Saleh, H. Piron, et al. 1998. Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression. Clin. Exp. Immunol. 113:183-189.
19. Gissmann, L. 1996. Immunologic responses to human papillomavirus infection. Obstet. Gynecol. Clin. North Am. 23:625-639.
20. Greslin, I., C. Mougin, and E. Seilles. 1998. The biology of papillomavirus infections. III. Immune response. Ann. Biol. Clin. (Paris) 56:267-276.
21. Hagensee, M.E., J.J. Carter, G.C. Wipf, et al. 1995. Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology 206:174-182.
22. Hagensee, M.E., L.A. Koutsky, S.K. Lee, et al. 2000. Detection of cervical antibodies to human papillomavirus type 16 (HPV- 16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions. J. Infect. Dis. 181:1234-1239.
23. Ho, G.Y., R. Bierman, L. Beardsley, et al. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
24. Hocini, H., A. Barra, L. Belec, et al. 1995. Systemic and secretory humoral immunity in the normal human vaginal tract. Scand. J. Immunol. 42:269-274.
25. Koutsky, L. 1997. Epidemiology of genital human papillomavirus infection. Am. J. Med. 102:3-8.
26. Koutsky, L.A., K.A. Ault, C.M. Wheeler, et al. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347:1645-1651.
27. Kutteh, W.H. 1999. Mucosal immunity in the human female reproductive tract, In: P.L. Ogra, J. Mestecky, M.E. Lamm, et al. (eds.), pp. 1423-1434. Handbook of Mucosal Immunology, Vol. 1. Academic Press, San Diego.
28. Kutteh, W.H., and J. Mestecky. 1994. Secretory immunity in the female reproductive tract. Am. J. Reprod. Immunol. 31:40-46.
29. Malejczyk, J., S. Majewski, and S. Jablonska. 1997. Cellular immunity in cutaneous and genital HPV infections. Clin. Dermatol. 15:261-274.
30. McGhee, J.R., J. Xu-Amano, C.J. Miller, et al. 1994. The common mucosal immune system: from basic principles to enteric vaccines with relevance for the female reproductive tract. Reprod. Fertil. Dev. 6:369-379.
31. Mitchell, E.A., L.A. Bergmeier, C. Doyle, et al. 1998. Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates. Eur. J. Immunol. 28:3066-3074.
32. Morrison, E.A., G.L. Goldberg, R.J. Hagan, et al. 1992. Self-administered home cervicovaginal lavage: a novel tool for the clinical-epidemiologic investigation of genital human papillomavirus infections. Am. J. Obstet. Gynecol. 167:104-107.
33. Mougin, C., B. Bernard, and M. Lab. 1997. Biology of papillomavirus infections. I. General characteristics. Ann. Biol. Clin. (Paris) 55:555-563.
34. Porgador, A., H.F. Staats, Y. Itoh, et al. 1998. Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue. Infect. Immun. 66:5876-5881.
35. Riethmuller, D., C. Gay, X. Bertrand, et al. 1999. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction. Diagn. Mol. Pathol. 8:157-164.
36. Riethmuller, D., and E. Seilles. 2000. Immune response of the female genital tract mucosa and mechanisms of papillomavirus counteractions. J. Gynecol. Obstet. Biol. Reprod. (Paris) 29:729-740.
37. Steinrauf, L.K., D. Shiuan, W.J. Yang, et al. 1999. Lysozyme association with nucleic acids. Biochem. Biophys. Res. Commun. 266:366-370.
38. Tjiong, M.Y., K. Zumbach, J.T. Schegget, et al. 2001. Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia. Viral Immunol. 14:415-424.
39. van der Strate, B.W., L. Beljaars, G. Molema, et al. 2001. Antiviral activities of lactoferrin. Antiviral Res. 52:225-239.
40. Vardy, D.A., O. Baadsgaard, E.R. Hansen, et al. 1990. The cellular immune response to human papillomavirus infection. Int. J. Dermatol. 29:603-610.
41. Woodworth, C.D. 2002. Hpv innate immunity. Front. Biosci. 7:D2058-D2071.